Anxiety Treatment Plan

• Name: [Client Name]
• Age: [Age]
• Diagnosis: [e.g., Generalized Anxiety Disorder F41.1, Panic Disorder F41.0, Social Anxiety Disorder F40.10]
• Date of plan: [Date]

• Primary symptoms: [worry/panic/avoidance patterns]
• Triggers: [situations or themes]
• Baseline measures: [GAD-7 score, panic frequency, avoidance behaviors]
• Impact on functioning: [work/school/social/daily activities]

• Goal 1:
• Description: [Specific, measurable goal, e.g., reduce GAD-7 score from X to below 10]
• Target Date: [Date]
• Interventions:
• 0: [e.g., Cognitive restructuring of worry thoughts]
• 1: [e.g., Daily relaxation or breathing practice]
• Progress Indicators:
• 0: [e.g., GAD-7 administered every 4 weeks]
• 1: [e.g., Client-reported worry intensity ratings]
• Goal 2:
• Description: [Specific, measurable goal, e.g., reduce avoidance of feared situations]
• Target Date: [Date]
• Interventions:
• 0: [e.g., Graduated exposure using fear hierarchy]
• 1: [e.g., Interoceptive exposure for panic symptoms]
• Progress Indicators:
• 0: [e.g., Number of exposure exercises completed weekly]
• 1: [e.g., Subjective distress ratings during exposures]

Primary approach: [CBT/ACT/exposure therapy]. Rationale: [evidence base for this anxiety presentation].

Sessions: [Frequency] for [Duration]. Review date: [Date].

Risk factors: [List if any]. Safety plan: [Details if needed].

Early warning signs: [symptoms to monitor]. Maintenance skills: [skills to continue]. Booster sessions: [plan if needed].

• Name: [Fictional example] Jordan M.
• Age: 29
• Diagnosis: Generalized Anxiety Disorder (F41.1)
• Date of plan: March 3, 2026

• Primary symptoms: persistent uncontrollable worry, muscle tension, sleep onset difficulty
• Triggers: work deadlines, health concerns, finances
• Baseline measures: GAD-7 score of 15 (moderate-severe); reports worry "most of the day" 5+ days per week
• Impact on functioning: procrastination at work, declining social invitations, 1-2 hours to fall asleep

• Goal 1:
• Description: Reduce GAD-7 score from 15 to below 8 within 12 weeks
• Target Date: May 26, 2026
• Interventions:
• 0: Weekly cognitive restructuring targeting catastrophic worry
• 1: Daily 10-minute progressive muscle relaxation practice
• Progress Indicators:
• 0: GAD-7 administered every 4 weeks
• 1: Daily worry log with intensity ratings (0-10)
• Goal 2:
• Description: Improve sleep onset to under 30 minutes at least 5 nights per week
• Target Date: May 26, 2026
• Interventions:
• 0: Stimulus control and sleep hygiene training
• 1: Scheduled worry time in early evening
• Progress Indicators:
• 0: Weekly sleep diary review
• 1: Client-reported sleep onset latency

Primary approach: cognitive behavioral therapy. Rationale: CBT is the first-line evidence-based treatment for GAD, with strong support for combining cognitive restructuring and applied relaxation.

Sessions: weekly for 12 weeks, then reassess. Review date: May 26, 2026.

Risk factors: none identified; denies suicidal ideation. Safety plan: not indicated at this time.

Early warning signs: return of nightly worry spirals, declining social plans. Maintenance skills: worry log, scheduled worry time, relaxation practice. Booster sessions: monthly check-ins for 3 months after weekly sessions end.